Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients

Authors: Liesbeth Hameetman, Suzan Commandeur, Jan Nico Bouwes Bavinck, Hermina C Wisgerhof, Frank R de Gruijl, Rein Willemze, Leon Mullenders, Cornelis P Tensen, Harry Vrieling

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

The risk of developing cutaneous squamous cell carcinoma (SCC) is markedly increased in organ transplant recipients (OTRs) compared to the normal population. Next to sun exposure, the immunosuppressive regimen is an important risk factor for the development of SCC in OTRs. Various gene mutations (e.g. TP53) and genetic alterations (e.g. loss of CDKN2A, amplification of RAS) have been found in SCCs. The aim of this genome-wide study was to identify pathways and genomic alterations that are consistently involved in the formation of SCCs and their precursor lesions, actinic keratoses (AKs).

Methods

To perform the analysis in an isogenic background, RNA and DNA were isolated from SCC, AK and normal (unexposed) epidermis (NS) from each of 13 OTRs. Samples were subjected to genome-wide expression analysis and genome SNP analysis using Illumina’s HumanWG-6 BeadChips and Infinium II HumanHap550 Genotyping BeadChips, respectively. mRNA expression results were verified by quantitative PCR.

Results

Hierarchical cluster analysis of mRNA expression profiles showed SCC, AK and NS samples to separate into three distinct groups. Several thousand genes were differentially expressed between epidermis, AK and SCC; most upregulated in SCCs were hyperproliferation related genes and stress markers, such as keratin 6 (KRT6), KRT16 and KRT17. Matching to oncogenic pathways revealed activation of downstream targets of RAS and cMYC in SCCs and of NFκB and TNF already in AKs. In contrast to what has been reported previously, genome-wide SNP analysis showed very few copy number variations in AKs and SCCs, and these variations had no apparent relationship with observed changes in mRNA expression profiles.

Conclusion

Vast differences in gene expression profiles exist between SCC, AK and NS from immunosuppressed OTRs. Moreover, several pathways activated in SCCs were already activated in AKs, confirming the assumption that AKs are the precursor lesions of SCCs. Since the drastic changes in gene expression appeared unlinked to specific genomic gains or losses, the causal events driving SCC development require further investigation. Other molecular mechanisms, such as DNA methylation or miRNA alterations, may affect gene expression in SCCs of OTRs. Further study is required to identify the mechanisms of early activation of NFκB and TNF, and to establish whether these pathways offer a feasible target for preventive intervention among OTRs.
Appendix
Available only for authorised users
Literature
1.
Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O’Sullivan B, Siskind V, van ver Woude FJ, Hardie IR: The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 1996, 61: 715-721. 10.1097/00007890-199603150-00008.CrossRefPubMed
2.
Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ: Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation. 2004, 77: 574-579. 10.1097/01.TP.0000108491.62935.DF.CrossRefPubMed
3.
Fortina AB, Piaserico S, Caforio AL, Abeni D, Alaibac M, Angelini A, Iliceto S, Peserico A: Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol. 2004, 140: 1079-1085. 10.1001/archderm.140.9.1079.CrossRefPubMed
4.
Glover MT, Deeks JJ, Raftery MJ, Cunningham J, Leigh IM: Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet. 1997, 349: 398-CrossRefPubMed
5.
Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA. 1991, 88: 10124-10128. 10.1073/pnas.88.22.10124.CrossRefPubMedPubMedCentral
6.
Ullrich SE: Mechanisms underlying UV-induced immune suppression. Mutat Res. 2005, 571: 185-205. 10.1016/j.mrfmmm.2004.06.059.CrossRefPubMed
7.
Proby CM, Harwood CA, Neale RE, Green AC, Euvrard S, Naldi L, Tessari G, Feltkamp MC, de Koning MN, Quint WG, et al: A case–control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant. 2011, 11: 1498-1508. 10.1111/j.1600-6143.2011.03589.x.CrossRefPubMed
8.
Nindl I, Gottschling M, Stockfleth E: Human papillomaviruses and non-melanoma skin cancer: Basic virology and clinical manifestations. Dis Markers. 2007, 23: 247-259.CrossRefPubMedPubMedCentral
9.
Arron ST, Ruby JG, Dybbro E, Ganem D, Derisi JL: Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol. 2011, 131: 1745-1753. 10.1038/jid.2011.91.CrossRefPubMedPubMedCentral
10.
Ko CJ: Actinic keratosis: facts and controversies. Clin Dermatol. 2010, 28: 249-253. 10.1016/j.clindermatol.2009.06.009.CrossRefPubMed
11.
McGregor JM, Berkhout RJ, Rozycka M, ter Schegget J, Rozycka M, Bouwes Bavinck JN, Crook T: p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene. 1997, 15: 1737-1740. 10.1038/sj.onc.1201339.CrossRefPubMed
12.
Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, Leffell DJ, Tarone RE, Brash DE: Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA. 1996, 93: 14025-14029. 10.1073/pnas.93.24.14025.CrossRefPubMedPubMedCentral
13.
Rebel H, Mosnier LO, Berg RJ, Westerman-de Vries A, van Steeg H, van Kranen HJ, de de Gruijl HJ: Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity. Cancer Res. 2001, 61: 977-983.PubMed
14.
de Graaf YG, Rebel H, Elghalbzouri A, Cramers P, Nellen RG, Willemze R, Bouwes Bavinck JN, de Gruijl FR: More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine. Exp Dermatol. 2008, 17: 349-355. 10.1111/j.1600-0625.2007.00651.x.CrossRefPubMed
15.
Boukamp P: Non-melanoma skin cancer: what drives tumor development and progression?. Carcinogenesis. 2005, 26: 1657-1667. 10.1093/carcin/bgi123.CrossRefPubMed
16.
Tsang DK, Crowe DL: The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines. Int J Oncol. 1999, 15: 519-523.PubMed
17.
Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR: Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization. Arch Dermatol. 2003, 139: 876-882. 10.1001/archderm.139.7.876.CrossRefPubMed
18.
Purdie KJ, Lambert SR, Teh MT, Chaplin T, Molloy G, Raghavan M, Kelsell DP, Leigh IM, Harwood CA, Proby CM, et al: Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer. 2007, 46: 661-669. 10.1002/gcc.20447.CrossRefPubMedPubMedCentral
19.
Purdie KJ, Harwood CA, Gulati A, Chaplin T, Lambert SR, Cerio R, Kelly GP, Cazier JB, Young BD, Leigh IM, et al: Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs. J Invest Dermatol. 2009, 129: 1562-1568. 10.1038/jid.2008.408.CrossRefPubMedPubMedCentral
20.
Rehman I, Takata M, Wu YY, Rees JL: Genetic change in actinic keratoses. Oncogene. 1996, 12: 2483-2490.PubMed
21.
van Haren R, Feldman D, Sinha AA: Systematic comparison of nonmelanoma skin cancer microarray datasets reveals lack of consensus genes. Br J Dermatol. 2009, 161: 1278-1287. 10.1111/j.1365-2133.2009.09338.x.CrossRefPubMed
22.
Hudson LG, Gale JM, Padilla RS, Pickett G, Alexander BE, Wang J, Kusewitt DF: Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes. Mol Carcinog. 2010, 49: 619-629. 10.1002/mc.20636.CrossRefPubMedPubMedCentral
23.
Padilla RS, Sebastian S, Jiang Z, Nindl I, Larson R: Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression. Arch Dermatol. 2010, 146: 288-293. 10.1001/archdermatol.2009.378.CrossRefPubMed
24.
Ra SH, Li X, Binder S: Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin. Mod Pathol. 2011, 24: 963-973.PubMed
25.
Hofbauer GF, Bouwes Bavinck JN, Euvrard S: Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol. 2010, 19: 473-482. 10.1111/j.1600-0625.2010.01086.x.CrossRefPubMed
26.
Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic explanation of Slaughter’s concept of field cancerization: evidence and clinical implications. Cancer Res. 2003, 63: 1727-1730.PubMed
27.
28.
Furge KA, Chen J, Koeman J, Swiatek P, Dykema K, Lucin K, Kahnoski R, Yang XJ, Teh BT: Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res. 2007, 67: 3171-3176. 10.1158/0008-5472.CAN-06-4571.CrossRefPubMed
29.
Gugasyan R, Voss A, Varigos G, Thomas T, Grumont RJ, Kaur P, Grigoriadis G, Gerondakis S: The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. Mol Cell Biol. 2004, 24: 5733-5745. 10.1128/MCB.24.13.5733-5745.2004.CrossRefPubMedPubMedCentral
30.
Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, et al: Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res. 2004, 64: 6511-6523. 10.1158/0008-5472.CAN-04-0852.CrossRefPubMed
31.
Rittie L, Kansra S, Stoll SW, Li Y, Gudjonsson JE, Shao Y, Michael LE, Fisher GJ, Johnson TM, Elder JT: Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am J Pathol. 2007, 170: 2089-2099. 10.2353/ajpath.2007.060537.CrossRefPubMedPubMedCentral
32.
Commandeur S, van Drongelen V, de Gruijl FR, Ghalbzouri AE: Epidermal growth factor receptor activation and inhibition in 3D in vitro models of normal skin and human cutaneous squamous cell carcinoma. Cancer Sci. 2012, 103: 2120-2126. 10.1111/cas.12026.CrossRefPubMed
33.
Pivarcsi A, Muller A, Hippe A, Rieker J, van Lierop A, Steinhoff M, Seeliger S, Kubitza R, Pippirs U, Meller S, et al: Tumor immune escape by the loss of homeostatic chemokine expression. Proc Natl Acad Sci USA. 2007, 104: 19055-19060. 10.1073/pnas.0705673104.CrossRefPubMedPubMedCentral
34.
Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, Orozco R, Copeland NG, Jenkins NA, McEvoy LM, et al: CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA. 1999, 96: 14470-14475. 10.1073/pnas.96.25.14470.CrossRefPubMedPubMedCentral
35.
Commandeur S, de Gruijl FR, Willemze R, Tensen CP, El Ghalbzouri A: An in vitro three-dimensional model of primary human cutaneous squamous cell carcinoma. Exp Dermatol. 2009, 18: 849-856. 10.1111/j.1600-0625.2009.00856.x.CrossRefPubMed
36.
Son KD, Kim TJ, Lee YS, Park GS, Han KT, Lim JS, Kang CS: Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin. J Surg Oncol. 2008, 97: 615-620. 10.1002/jso.21006.CrossRefPubMed
37.
Tsukifuji R, Tagawa K, Hatamochi A, Shinkai H: Expression of matrix metalloproteinase-1, -2 and −3 in squamous cell carcinoma and actinic keratosis. Br J Cancer. 1999, 80: 1087-1091. 10.1038/sj.bjc.6690468.CrossRefPubMedPubMedCentral
38.
Chebassier N, Leroy S, Tenaud I, Knol AC, Dreno B: Overexpression of MMP-2 and MMP-9 in squamous cell carcinomas of immunosuppressed patients. Arch Dermatol Res. 2002, 294: 124-126. 10.1007/s00403-002-0299-x.CrossRefPubMed
39.
Ahmed ST, Darnell JE: Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. Biochem Biophys Res Commun. 2009, 378: 821-825. 10.1016/j.bbrc.2008.11.147.CrossRefPubMed
40.
Peiffer DA, Le JM, Steemers FJ, Chang W, Jenniges T, Garcia F, Haden K, Li J, Shaw CA, Belmont J, et al: High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res. 2006, 16: 1136-1148. 10.1101/gr.5402306.CrossRefPubMedPubMedCentral
41.
Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, et al: Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010, 467: 1114-1117. 10.1038/nature09515.CrossRefPubMedPubMedCentral
42.
Ashton KJ, Carless MA, Griffiths LR: Cytogenetic alterations in nonmelanoma skin cancer: a review. Genes Chromosomes Cancer. 2005, 43: 239-248. 10.1002/gcc.20183.CrossRefPubMed
43.
Rehman I, Quinn AG, Takata M, Taylor AE, Rees JL: Low frequency of allelic loss in skin tumours from immunosuppressed individuals. Br J Cancer. 1997, 76: 757-759. 10.1038/bjc.1997.457.CrossRefPubMedPubMedCentral
44.
O’Donovan P, Perrett CM, Zhang X, Montaner B, Xu YZ, Harwood CA, McGregor JM, Walker SL, Hanaoka F, Karran P: Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005, 309: 1871-1874. 10.1126/science.1114233.CrossRefPubMedPubMedCentral
45.
Wisgerhof HC, van der Geest LG, de Fijter JW, Haasnoot GW, Claas FH, le Cessie S, Willemze R, Bouwes Bavinck JN: Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol. 2011, 35: 105-111. 10.1016/j.canep.2010.07.002.CrossRefPubMed
46.
Breuninger H, Black B, Rassner G: Microstaging of squamous cell carcinomas. Am J Clin Pathol. 1990, 94: 624-627.CrossRefPubMed
47.
Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16: 1215-10.1093/nar/16.3.1215.CrossRefPubMedPubMedCentral
48.
Du P, Kibbe WA, Lin SM: lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008, 24: 1547-1548. 10.1093/bioinformatics/btn224.CrossRefPubMed
49.
50.
Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: Article3-PubMed
51.
Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009, 4: 44-57.CrossRef
52.
Ho Sui SJ, Mortimer JR, Arenillas DJ, Brumm J, Walsh CJ, Kennedy BP, Wasserman WW: oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res. 2005, 33: 3154-3164. 10.1093/nar/gki624.CrossRefPubMedPubMedCentral
53.
Edgar R, Domrachev M, Lash AE: Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30: 207-210. 10.1093/nar/30.1.207.CrossRefPubMedPubMedCentral
54.
Vandesompele J, de Preter K, Pattyn F, Poppe B, van Roy N, de Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3: RESEARCH0034-CrossRefPubMedPubMedCentral
55.
Hellemans J, Mortier G, de Paepe A, Speleman F, Vandesompele J: qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8: R19-10.1186/gb-2007-8-2-r19.CrossRefPubMedPubMedCentral
Metadata
Title
Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients
Authors
Liesbeth Hameetman
Suzan Commandeur
Jan Nico Bouwes Bavinck
Hermina C Wisgerhof
Frank R de Gruijl
Rein Willemze
Leon Mullenders
Cornelis P Tensen
Harry Vrieling
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-58

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue

Research article

Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells

Research article

Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression

Research article

Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells

Study protocol

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

Research article

Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics

Research article

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits